Fred Alger Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,635	Closed	-$608K	–	452
2025 Q1	$608K	Buy	+27,635	New	+$608K	﹤0.01%	346
2024 Q4	–	Sell	-21,128	Closed	-$564K	–	430
2024 Q3	$564K	Buy	+21,128	New	+$564K	﹤0.01%	374